Thermo Fisher Scientific Inc. (TMO) Shares Sold by Tdam USA Inc.

Tdam USA Inc. reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 8.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,805 shares of the medical research company’s stock after selling 519 shares during the quarter. Tdam USA Inc.’s holdings in Thermo Fisher Scientific were worth $1,299,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the company. Advisors Asset Management Inc. raised its holdings in shares of Thermo Fisher Scientific by 11.7% in the second quarter. Advisors Asset Management Inc. now owns 93,813 shares of the medical research company’s stock valued at $19,432,000 after acquiring an additional 9,832 shares in the last quarter. Winslow Evans & Crocker Inc. raised its holdings in shares of Thermo Fisher Scientific by 125.0% in the third quarter. Winslow Evans & Crocker Inc. now owns 10,038 shares of the medical research company’s stock valued at $2,452,000 after acquiring an additional 5,576 shares in the last quarter. Cape Cod Five Cents Savings Bank raised its holdings in shares of Thermo Fisher Scientific by 76.6% in the third quarter. Cape Cod Five Cents Savings Bank now owns 2,313 shares of the medical research company’s stock valued at $565,000 after acquiring an additional 1,003 shares in the last quarter. First Hawaiian Bank bought a new stake in shares of Thermo Fisher Scientific in the third quarter valued at about $3,186,000. Finally, Andra AP fonden raised its holdings in shares of Thermo Fisher Scientific by 21.7% in the third quarter. Andra AP fonden now owns 17,400 shares of the medical research company’s stock valued at $4,247,000 after acquiring an additional 3,100 shares in the last quarter. 91.80% of the stock is currently owned by institutional investors.

In other Thermo Fisher Scientific news, Director Tyler Jacks sold 1,100 shares of Thermo Fisher Scientific stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $251.98, for a total value of $277,178.00. Following the transaction, the director now owns 5,879 shares in the company, valued at $1,481,390.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gregory J. Herrema sold 17,235 shares of Thermo Fisher Scientific stock in a transaction dated Thursday, November 29th. The shares were sold at an average price of $247.00, for a total value of $4,257,045.00. Following the completion of the transaction, the insider now owns 26,446 shares in the company, valued at approximately $6,532,162. The disclosure for this sale can be found here. Insiders sold 32,607 shares of company stock worth $7,972,085 in the last quarter. 0.49% of the stock is owned by insiders.

TMO has been the subject of several recent research reports. Cleveland Research downgraded Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Thursday, October 18th. Robert W. Baird lifted their price objective on Thermo Fisher Scientific from $256.00 to $264.00 and gave the company an “outperform” rating in a report on Thursday, October 25th. Morgan Stanley lifted their price objective on Thermo Fisher Scientific from $254.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, October 25th. Finally, Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $247.00 price objective for the company in a report on Friday, October 26th. Three equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and an average price target of $275.10.

TMO traded up $1.42 on Monday, hitting $244.93. The company had a trading volume of 7,527 shares, compared to its average volume of 1,696,646. Thermo Fisher Scientific Inc. has a 12-month low of $194.51 and a 12-month high of $253.91. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.71 and a quick ratio of 1.23. The firm has a market capitalization of $98.03 billion, a PE ratio of 22.05, a price-to-earnings-growth ratio of 1.60 and a beta of 1.14.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.19 by $0.06. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. The company had revenue of $6.51 billion for the quarter, compared to analyst estimates of $6.26 billion. During the same quarter in the previous year, the firm earned $2.79 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, sell-side analysts expect that Thermo Fisher Scientific Inc. will post 12.14 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.chaffeybreeze.com/2019/02/11/thermo-fisher-scientific-inc-tmo-shares-sold-by-tdam-usa-inc.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Story: Understanding Specialty Certificates of Deposit

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply